Export trial: Ablation for persistent atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a new approach to catheter ablation for people with persistent atrial fibrillation (a type of irregular heartbeat). It may be an option if you have not responded well to or could not tolerate a rhythm-control medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older and have persistent atrial fibrillation (constant irregular heartbeat lasting more than a week).
- You have tried at least one rhythm-control medicine (like flecainide or amiodarone) and it did not work or caused side effects.
- This is your first time having a catheter ablation for atrial fibrillation.
- You do not have recent heart problems, such as a heart attack or stroke within the last 3 months, or severe valve disease or heart failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to treat atrial fibrillation by using a catheter to target the specific areas in the heart that trigger the irregular heartbeat. If you have persistent atrial fibrillation and haven't had prior catheter ablation, you may be eligible to join.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This trial tests whether one ablation approach works better than another for paroxysmal (intermittent) atrial fibrillation by targeting the heart’s “triggers” and “substrate” (where the rhythm problem is). If you qualify, you’ll be randomly assigned to one of two ablation energy methods during a pulmonary vein isolation procedure.
This trial studies catheter ablation, a procedure that targets heart rhythm triggers, for people with atrial fibrillation (an irregular heartbeat). It may help improve rhythm control, but you must meet specific heart and testing requirements and avoid certain conditions.
This study compares two types of ablation (a procedure that uses energy to fix irregular heartbeats) for people with persistent atrial fibrillation. It tests whether adding extra treatment to the back of the heart's left upper chamber helps improve outcomes compared to standard treatment alone.
This trial tests if a repeat catheter ablation procedure can help people with persistent atrial fibrillation who still have symptoms after their first procedure. If you've already had a pulmonary vein isolation, this study may offer a chance at better rhythm control.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.